ZIM Laboratories and Globalpharma Join Forces to Revolutionize Drug Delivery in GCC

ZIM Laboratories Ltd has announced a strategic collaboration with Globalpharma, a leading pharmaceutical manufacturer in the UAE, to introduce innovative drug delivery solutions in the Gulf Cooperation Council (GCC) region. This partnership aims to leverage cutting-edge Oral Dispersible Film (ODF) technology to enhance patient-centric healthcare solutions.  

Key Highlights:  
- The collaboration focuses on EU-certified ODF technology, which offers thin, fast-dissolving strips that melt in the mouth without water, ideal for children, elderly patients, and those with swallowing difficulties.  
- ZIM Laboratories has entered into a license agreement with Globalpharma, enabling localized production of ODFs at Globalpharma’s state-of-the-art facility in the UAE.  
- Globalpharma plans to commercialize a portfolio of ten ODF-based products, catering to various therapeutic areas and setting a benchmark for pharmaceutical manufacturing in the Middle East.  
- The partnership aligns with the UAE’s vision to become a global hub for pharmaceutical innovation and advanced drug manufacturing.  
- This collaboration was unveiled at the AIM Congress 2025, highlighting the growing influence of the GCC region in global pharmaceutical advancements.  

This partnership underscores the commitment of both companies to improving patient compliance and treatment efficacy through innovative drug delivery systems. It also positions the GCC region as a key player in the global pharmaceutical landscape.  

Sources: Big News Network, Zawya, Dubai Investments Press Release